[Treatment of methimazole-induced agranulocytosis with granulocyte-macrophage colony stimulating factor].
The authors treated a patient with methimazol (Metothyrin)-induced agranulocytosis with human recombinant granulocyte-macrophage colony stimulating factor (GM-CSF). On day seven, after combined antibiotics, corticosteroid and at a dose of 270 ug daily subcutaneous GM-CSF therapy the septic state of the patients rapidly cured and the leucocytes reached the peripheric blood. No side effects were found. The publication of this case history might help to determine the place of human GM-CSF-s therapy in the treatment of agranulocytosis of different origin.
Somogyi
A
A
Belgyógyászati Klinika, Semmelweis Orvostudományi Egyetem, Budapest.
Werling
K
K
Rosta
A
A
Láng
I
I
D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007958:Leukocyte Count / Q000187:drug effects; D008713:Methimazole / Q000009:adverse effects*
D008713:Methimazole; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
Metothyrin indukált agranulocytosis kezelése granulocyta-macrophag colonia stimuláló faktorral.